ArticleMolecular biology reports2026
Association of CLCA4 genetic variation with non-obstructive azoospermia and its potential interaction with Y-chromosome microdeletions.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNon-obstructive azoospermia (NOA) is a severe form of male infertility with heterogeneous genetic determinants. While Y-chromosome microdeletions are established contributors, the role of autosomal variants in modulating disease susceptibility and phenotypic variability remains poorly understood.
methodsA case-control study was conducted comprising 87 NOA patients and 50 fertile controls. CLCA4 variants were analyzed using tetra-primer amplification refractory mutation system PCR (ARMS-PCR) and Sanger sequencing. Y-chromosome microdeletions were assessed by multiplex PCR targeting AZFa, AZFb, and AZFc regions. Logistic regression analyses were adjusted for age and body mass index (BMI).
resultsMissense variant rs763334876 and intronic variant rs79455835 were detected exclusively in patients and showed significant associations with NOA risk, although these estimates were imprecise due to wide confidence intervals. Y-chromosome microdeletions were identified in 20.7% of patients and were more frequently observed among individuals harboring CLCA4 variants. In silico analyses suggested potential deleterious effects of coding variants, supporting a possible functional role.
conclusionThese findings indicate that CLCA4 genetic variation is associated with NOA and may contribute to disease susceptibility. The observed enrichment of variants among patients carrying Y-chromosome microdeletions suggests a possible relationship between autosomal and chromosomal defects that warrants further investigation. Further functional studies are required to validate the biological role of these variants.
Indexed as
Identifiers
42397533What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.